197 related articles for article (PubMed ID: 34481945)
21. Denosumab and sclerotherapy for recurrent spinal aneurysmal bone cyst in a child.
Singh R; Madasswery S; Colman M; Kent PM
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38589235
[TBL] [Abstract][Full Text] [Related]
22. The treatment of aneurysmal bone cysts.
van Geloven TPG; van de Sande MAJ; van der Heijden L
Curr Opin Pediatr; 2023 Feb; 35(1):131-137. PubMed ID: 36409159
[TBL] [Abstract][Full Text] [Related]
23. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts.
Lange T; Stehling C; Fröhlich B; Klingenhöfer M; Kunkel P; Schneppenheim R; Escherich G; Gosheger G; Hardes J; Jürgens H; Schulte TL
Eur Spine J; 2013 Jun; 22(6):1417-22. PubMed ID: 23455951
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
25. How safe and effective is denosumab for bone giant cell tumour?
Errani C; Tsukamoto S; Mavrogenis AF
Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421
[TBL] [Abstract][Full Text] [Related]
26. Denosumab Therapy in the Management of Aneurysmal Bone Cysts: A Comprehensive Literature Review.
Alhumaid I; Abu-Zaid A
Cureus; 2019 Jan; 11(1):e3989. PubMed ID: 30972268
[TBL] [Abstract][Full Text] [Related]
27. Aneurysmal bone cyst and giant cell tumor of the foot.
Casadei R; Ruggieri P; Moscato M; Ferraro A; Picci P
Foot Ankle Int; 1996 Aug; 17(8):487-95. PubMed ID: 8863029
[TBL] [Abstract][Full Text] [Related]
28. Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
Sydlik C; Dürr HR; Pozza SB; Weißenbacher C; Roeb J; Schmidt H
World J Pediatr; 2020 Oct; 16(5):520-527. PubMed ID: 32776272
[TBL] [Abstract][Full Text] [Related]
29. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
[TBL] [Abstract][Full Text] [Related]
30. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
31. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
[TBL] [Abstract][Full Text] [Related]
32. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
[TBL] [Abstract][Full Text] [Related]
33. Aneurysmal bone cyst of the spine in adult patients: A systematic review and comparison of primary vs secondary lesions.
Palmisciano P; Hunter M; Lokesh N; Bin Alamer O; Scalia G; Giammalva GR; Maugeri R; Iacopino DG; Umana GE; Haider AS
J Clin Neurosci; 2022 Jun; 100():15-22. PubMed ID: 35367732
[TBL] [Abstract][Full Text] [Related]
34. Chondroblastoma Expresses RANKL by RNA In Situ Hybridization and May Respond to Denosumab Therapy.
Suster DI; Kurzawa P; Neyaz A; Jarzembowski JA; Lozano-Calderon S; Raskin K; Schwab J; Choy E; Chebib I; Deshpande V
Am J Surg Pathol; 2020 Dec; 44(12):1581-1590. PubMed ID: 32826531
[TBL] [Abstract][Full Text] [Related]
35. Severe hypercalcemia following denosumab treatment in a juvenile patient.
Setsu N; Kobayashi E; Asano N; Yasui N; Kawamoto H; Kawai A; Horiuchi K
J Bone Miner Metab; 2016 Jan; 34(1):118-22. PubMed ID: 26056018
[TBL] [Abstract][Full Text] [Related]
36. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
37. Pathological Fractures in Benign Bone Lesions - Diagnosis and Therapy.
Spodeck D; Guder W; Streitbürger A; Dudda M; Podleska LE; Nottrott M; Hardes J
Z Orthop Unfall; 2024 Feb; 162(1):69-78. PubMed ID: 35882354
[TBL] [Abstract][Full Text] [Related]
38. [Benign tumours and tumour-like lesions of the bone : General treatment principles].
Fritzsche H; Schaser KD; Hofbauer C
Orthopade; 2017 Jun; 46(6):484-497. PubMed ID: 28451704
[TBL] [Abstract][Full Text] [Related]
39. Minimally invasive treatment of aneurysmal bone cysts: Systematic literature review.
Cottalorda J; Louahem Sabah D; Joly Monrigal P; Jeandel C; Delpont M
Orthop Traumatol Surg Res; 2022 Jun; 108(4):103272. PubMed ID: 35331923
[TBL] [Abstract][Full Text] [Related]
40. Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone.
Palmerini E; Staals EL; Jones LB; Donati DM; Longhi A; Randall RL
Curr Treat Options Oncol; 2020 Jul; 21(8):68. PubMed ID: 32623530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
